Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Velocity11, M.E. Muller Institute for Structural Biology, Veeco Instruments, Promega

Premium
Agilent Closes Acquisition of Lab Automation Firm Velocity11
 
Agilent Technologies said recently that it has completed the acquisition of Velocity11, a developer of automated liquid handling and laboratory robotics for the life science market.
 
Financial details of the transaction were not disclosed.
 
Agilent announced its plan to purchase the privately held firm last month.
 
The company said that it expects the acquisition to give it “more comprehensive suite of workflow solutions” for the pharmaceutical, biotech, and academic research markets.
 
Agilent said that “substantially all” of Velocity11's 150 employees have joined Agilent.
 
Velocity11 is based in Menlo Park, Calif., and has a second office in Melbourn, UK.
 

 
Swiss Institute Using Veeco's BioScope II
 
The M.E. Muller Institute for Structural Biology in Basel, Switzerland, will use Veeco Instruments’ Bioscope II atomic force microscope for translational research, Veeco said this week.
 
Under an agreement signed in the fourth quarter of 2007, MSB will use the tool for biological imaging beyond the diffraction limit of light and to measure nanomechanical properties of single biomolecules, cells, and tissues, said Sebastian Tille, Veeco’s senior life science product marketing manager.
 
The company said it will work with MSB to identify novel ways to apply the microscope to life sciences research.
 
Financial terms of the agreement were not released.
 

 
Promega to Open Office in Sweden This Month
 
Promega said recently that it will open an office in Stockholm this month to offer its products and services directly to the Swedish research community.
 
The company, based in Madison, Wis., previously offered its products in Sweden through a distribution deal with SDS BioSciences. 
 
The company has hired Patrick Van de Velde as general manager of the office.
 
In a statement, William Linton, CEO of Promega said that Sweden has the fourth-largest biotech industry in Europe with 48,000 full-time employees in R&D and the highest R&D expenditure per capita.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.